Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study

Detalles Bibliográficos
Autores principales: Sourij, Caren, Aziz, Faisal, Kojzar, Harald, Obermayer, Anna M., Sternad, Christoph, Müller, Alexander, Tripolt, Norbert J., Pferschy, Peter N., Aberer, Felix, Schlenke, Peter, Kleinhappl, Barbara, Stradner, Martin, Sareban, Nazanin, Moritz, Martina, Dominguez‐Villar, Margarita, Oliver, Nick, Steinmetz, Ivo, Sourij, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538806/
https://www.ncbi.nlm.nih.gov/pubmed/36057945
http://dx.doi.org/10.1111/dom.14855
_version_ 1784803399314702336
author Sourij, Caren
Aziz, Faisal
Kojzar, Harald
Obermayer, Anna M.
Sternad, Christoph
Müller, Alexander
Tripolt, Norbert J.
Pferschy, Peter N.
Aberer, Felix
Schlenke, Peter
Kleinhappl, Barbara
Stradner, Martin
Sareban, Nazanin
Moritz, Martina
Dominguez‐Villar, Margarita
Oliver, Nick
Steinmetz, Ivo
Sourij, Harald
author_facet Sourij, Caren
Aziz, Faisal
Kojzar, Harald
Obermayer, Anna M.
Sternad, Christoph
Müller, Alexander
Tripolt, Norbert J.
Pferschy, Peter N.
Aberer, Felix
Schlenke, Peter
Kleinhappl, Barbara
Stradner, Martin
Sareban, Nazanin
Moritz, Martina
Dominguez‐Villar, Margarita
Oliver, Nick
Steinmetz, Ivo
Sourij, Harald
author_sort Sourij, Caren
collection PubMed
description
format Online
Article
Text
id pubmed-9538806
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-95388062022-10-11 Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study Sourij, Caren Aziz, Faisal Kojzar, Harald Obermayer, Anna M. Sternad, Christoph Müller, Alexander Tripolt, Norbert J. Pferschy, Peter N. Aberer, Felix Schlenke, Peter Kleinhappl, Barbara Stradner, Martin Sareban, Nazanin Moritz, Martina Dominguez‐Villar, Margarita Oliver, Nick Steinmetz, Ivo Sourij, Harald Diabetes Obes Metab Research Letters Blackwell Publishing Ltd 2022-09-15 /pmc/articles/PMC9538806/ /pubmed/36057945 http://dx.doi.org/10.1111/dom.14855 Text en © 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letters
Sourij, Caren
Aziz, Faisal
Kojzar, Harald
Obermayer, Anna M.
Sternad, Christoph
Müller, Alexander
Tripolt, Norbert J.
Pferschy, Peter N.
Aberer, Felix
Schlenke, Peter
Kleinhappl, Barbara
Stradner, Martin
Sareban, Nazanin
Moritz, Martina
Dominguez‐Villar, Margarita
Oliver, Nick
Steinmetz, Ivo
Sourij, Harald
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title_full Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title_fullStr Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title_full_unstemmed Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title_short Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC‐DM cohort study
title_sort severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: the prospective covac‐dm cohort study
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538806/
https://www.ncbi.nlm.nih.gov/pubmed/36057945
http://dx.doi.org/10.1111/dom.14855
work_keys_str_mv AT sourijcaren severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT azizfaisal severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT kojzarharald severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT obermayerannam severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT sternadchristoph severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT mulleralexander severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT tripoltnorbertj severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT pferschypetern severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT abererfelix severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT schlenkepeter severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT kleinhapplbarbara severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT stradnermartin severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT sarebannazanin severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT moritzmartina severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT dominguezvillarmargarita severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT olivernick severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT steinmetzivo severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy
AT sourijharald severeacuterespiratorysyndromecoronavirus2spikeantibodyleveldeclineismorepronouncedafterthesecondvaccinationbutresponsetothethirdvaccinationissimilarinpeoplewithtype1andtype2diabetescomparedwithhealthycontrolstheprospectivecovacdmcohortstudy

Ejemplares similares